These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 380326)

  • 21. Sensitization by platelet transfusion.
    Brand A
    Schweiz Med Wochenschr; 1991 Mar; 121(13):467-9. PubMed ID: 2031162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet replacement therapy: a clinical assessment.
    Hester JP; McCredie KB; Freireich EJ
    Prog Clin Biol Res; 1978; 28():281-93. PubMed ID: 752154
    [No Abstract]   [Full Text] [Related]  

  • 23. Successful transfusion of platelets "mismatched" for HLA antigens to alloimmunized thrombocytopenic patients.
    Duquesnoy RJ; Filip DJ; Rodey GE; Rimm AA; Aster RH
    Am J Hematol; 1977; 2(3):219-26. PubMed ID: 596366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of the HLA-system in clinical medicine.
    van Rood JJ
    Schweiz Med Wochenschr; 1993 Jan; 123(3):85-92. PubMed ID: 8426953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Platelet pool versus single platelet donor].
    Rev Fr Transfus Immunohematol; 1987 Nov; 30(4):293-319. PubMed ID: 2832927
    [No Abstract]   [Full Text] [Related]  

  • 26. Use of leucocyte-poor blood components and HLA-matched-platelet donors to prevent HLA alloimmunization.
    Murphy MF; Metcalfe P; Thomas H; Eve J; Ord J; Lister TA; Waters AH
    Br J Haematol; 1986 Mar; 62(3):529-34. PubMed ID: 3954967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet supportive care: immunological and clinical aspects.
    Brand A; van Leeuwen A; Niterink A; Langerak J; Eernisse JG; van Rood JJ
    Neth J Med; 1979; 22(4):133-7. PubMed ID: 481651
    [No Abstract]   [Full Text] [Related]  

  • 28. Identifying human leukocyte antigen (HLA)-compatible platelets using the Matchmaker programme in alloimmunised platelet-refractory patients.
    Kreuter JD
    Transfus Med; 2020 Feb; 30(1):5-6. PubMed ID: 32187786
    [No Abstract]   [Full Text] [Related]  

  • 29. Platelet refractoriness--practical approaches and ongoing dilemmas in patient management.
    Stanworth SJ; Navarrete C; Estcourt L; Marsh J
    Br J Haematol; 2015 Nov; 171(3):297-305. PubMed ID: 26194869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [HLA and transfusion: new approaches with Luminex™ technology].
    Giannoli C; Nguyen TK; Dubois V
    Transfus Clin Biol; 2011 Apr; 18(2):218-23. PubMed ID: 21397543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Platelet and granulocyte transfusion and HLA (author's transl)].
    Juji T
    Rinsho Byori; 1978 Oct; 26(10):856-60. PubMed ID: 713087
    [No Abstract]   [Full Text] [Related]  

  • 32. Alloimmunisation to HLA antigens following transfusion with leucocyte-poor and purified platelet suspensions.
    Fisher M; Chapman JR; Ting A; Morris PJ
    Vox Sang; 1985; 49(5):331-5. PubMed ID: 3909636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elective transfusion or HLA matching.
    Saueracker GC; Dawkins RL; Hurst P; Saker BM; Thatcher G; Haywood EF
    Transplantation; 1980 Nov; 30(5):394-5. PubMed ID: 7006173
    [No Abstract]   [Full Text] [Related]  

  • 34. Epitope-based matching for HLA-alloimmunized platelet refractoriness in patients with hematologic diseases.
    Pai SC; Lo SC; Lin Tsai SJ; Chang JS; Lin DT; Lin KS; Lin LI
    Transfusion; 2010 Nov; 50(11):2318-27. PubMed ID: 20497513
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet crossmatch testing for donor selection.
    Slichter SJ
    Prog Clin Biol Res; 1982; 88():153-64. PubMed ID: 7100207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of in vitro assays in selection of compatible platelet donors.
    Tosato G; Appelbaum FR; Trapani RJ; Dowling R; Deisseroth AB
    Transfusion; 1980; 20(1):47-54. PubMed ID: 7355471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet transfusion therapy in an alloimmunized patient. The value of crossmatch procedures for donor selection.
    Hecht T; Wolf JL; Mraz L; Scott EP; Patz LD
    JAMA; 1982 Nov; 248(18):2301-3. PubMed ID: 6752444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [HLA compatibility and transfusion of a platelet concentrate--a necessary prerequisite for the successful transfusion of platelet concentrates in patients with HLA antibodies].
    Májský A; Korínková P; Vítek A
    Cas Lek Cesk; 1986 Mar; 125(12):363-5. PubMed ID: 3955595
    [No Abstract]   [Full Text] [Related]  

  • 39. Transfusions, HLA matching and kidney transplantations.
    N Engl J Med; 1979 Feb; 300(5):256-8. PubMed ID: 366405
    [No Abstract]   [Full Text] [Related]  

  • 40. [Transfusion of platelet concentrates].
    Rieux C; Lee K; Lavaud A; Bierling P
    Ann Med Interne (Paris); 1999 Dec; 150(8):631-41. PubMed ID: 10686645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.